Early Onset of TNFα-Driven Arthritis, Auto-inflammation, and Progressive Loss of Vision in a Patient with ALPK1 Mutation
- PMID: 35235128
- PMCID: PMC9166835
- DOI: 10.1007/s10875-022-01214-8
Early Onset of TNFα-Driven Arthritis, Auto-inflammation, and Progressive Loss of Vision in a Patient with ALPK1 Mutation
Conflict of interest statement
BS has served as consultant for Abbvie, Arena, BMS, Boehringer, Celgene, Falk, Janssen, Lilly, Pfizer, Prometheus, and Takeda and received speaker’s fees from Abbvie, CED Service GmbH, Falk, Ferring, Janssen, Novartis, Pfizer, and Takeda (served as a representative of the Charité). The other authors declare no competing interests.
Figures

Comment on
-
ALPK1 Gene Mutations Drive Autoinflammation with Ectodermal Dysplasia and Progressive Vision Loss.J Clin Immunol. 2021 Oct;41(7):1671-1673. doi: 10.1007/s10875-021-01087-3. Epub 2021 Jun 22. J Clin Immunol. 2021. PMID: 34159509 No abstract available.
References
-
- Jamilloux Y, Mathis T, Grunewald O, Dollfuss H, Henry T, Sève P, et al. ALPK1 gene mutations drive autoinflammation with ectodermal dysplasia and progressive vision loss. J Clin Immunol. 2021. - PubMed
-
- Weinhold KJ, Bukowski JF, Brennan TV, Noveck RJ, Staats JS, Lin L, et al. Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers. Clin Immunol. 2018;191:10–20. doi: 10.1016/j.clim.2018.03.002. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical